These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20635753)

  • 1. Facilitated PCI: crossing the bridge with lessons learned.
    Mishra S; Bahl VK
    Indian Heart J; 2009; 61(5):410-2. PubMed ID: 20635753
    [No Abstract]   [Full Text] [Related]  

  • 2. [The MULTISTRATEGY study].
    Danzi GB; Marzocchi A
    G Ital Cardiol (Rome); 2009 Jun; 10(6):353-7. PubMed ID: 19603605
    [No Abstract]   [Full Text] [Related]  

  • 3. [The FATA study].
    Merlini PA; Valgimigli M
    G Ital Cardiol (Rome); 2009 Jun; 10(6):358-63. PubMed ID: 19603606
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between patient's risk profile and benefits in mortality from adjunctive abciximab to mechanical revascularization for ST-segment elevation myocardial infarction: a meta-regression analysis of randomized trials.
    De Luca G; Suryapranata H; Stone GW; Antoniucci D; Tcheng JE; Neumann FJ; Bonizzoni E; Topol EJ; Chiariello M
    J Am Coll Cardiol; 2006 Feb; 47(3):685-6. PubMed ID: 16458158
    [No Abstract]   [Full Text] [Related]  

  • 5. [The AIDA STEMI study].
    Prati F; Limbruno U
    G Ital Cardiol (Rome); 2013 Oct; 14(10):631-5. PubMed ID: 24121885
    [No Abstract]   [Full Text] [Related]  

  • 6. Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarction.
    Gum PA; Lincoff AM
    Int J Clin Pract; 2003; 57(1):43-8. PubMed ID: 12587942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
    Taglieri N; Saia F; Guiducci V; Tondi S; Conrotto F; Marrozzini C; Rocchi G; Biagini E; Reggiani ML; Giacometti P; Piovaccari G; Manari A; Marzocchi A;
    Am J Cardiol; 2009 Mar; 103(6):785-90. PubMed ID: 19268732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MULTISTRATEGY and FATA: merits, limits and troubles of no profit clinical trials in acute myocardial infarction].
    Savonitto S
    G Ital Cardiol (Rome); 2009 Jun; 10(6):364-5. PubMed ID: 19603607
    [No Abstract]   [Full Text] [Related]  

  • 9. Abciximab in the treatment of ST-segment elevation myocardial infarction.
    Tan DS; Sim DK; Chan ES; Tan RS
    JAMA; 2005 Oct; 294(14):1760-1; author reply 1761. PubMed ID: 16219877
    [No Abstract]   [Full Text] [Related]  

  • 10. On the use of abciximab in percutaneous coronary intervention.
    Iversen AZ
    Dan Med Bull; 2011 Aug; 58(8):B4312. PubMed ID: 21827726
    [No Abstract]   [Full Text] [Related]  

  • 11. [The FINESSE trial].
    Petronio AS; Piscione F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):1-5. PubMed ID: 19292014
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
    Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarction.
    De Luca G; Suryapranata H; Grimaldi R; Chiariello M
    QJM; 2005 Sep; 98(9):633-41. PubMed ID: 16040669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stents are the CADILLAC of care. Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications.
    SoRelle R
    Circulation; 2002 Apr; 105(14):e9094-5. PubMed ID: 11942340
    [No Abstract]   [Full Text] [Related]  

  • 15. Abciximab in coronary intervention for acute myocardial infarction and stable ischemic heart disease: early investment for growing benefit.
    Ferenczi EA; Malik IS; Mayet J; Foale RA; Francis DP
    J Invasive Cardiol; 2008 Sep; 20(9):437-41. PubMed ID: 18762671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Workshop II--Clinical and therapeutic pathways].
    Ital Heart J; 2005 Nov; 6 Suppl 6():12S-26S. PubMed ID: 16491742
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of c7E3 Fab in conjunction with primary coronary stenting for acute myocardial infarctions complicated by cardiogenic shock.
    Schultz RD; Heuser RR; Hatler C; Frey D
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):143-8. PubMed ID: 8922314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial.
    Nikolsky E; Aymong ED; Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Cohen DA; Negoita M; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2004 Aug; 44(3):547-53. PubMed ID: 15358018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery stenting during acute myocardial infarction in patients treated with IIb/IIIa anti-platelet antibodies: early outcome results.
    Murdock DK; Hoffman MT; Logemann TN; Kaufman JS; Engelmeier RS
    Wis Med J; 1996 Dec; 95(12):867-71. PubMed ID: 8993226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    Tcheng JE; Kandzari DE; Grines CL; Cox DA; Effron MB; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Mehran R; Stone GW;
    Circulation; 2003 Sep; 108(11):1316-23. PubMed ID: 12939213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.